File Download
  Links for fulltext
     (May Require Subscription)
  • Find via Find It@HKUL
Supplementary

Conference Paper: EBUS-TBNA gives adequate tissue information on cell type in lung cancer

TitleEBUS-TBNA gives adequate tissue information on cell type in lung cancer
Authors
Wong, MKYLam, DIp, MHo, J
KeywordsMedical sciences
Issue Date2013
PublisherHong Kong Academy of Medicine Press. The Journal's web site is located at http://www.hkmj.org.hk
Citation
The 18th Medical Research Conference (MRC 2013), Department of Medicine, The University of Hong Kong, Hong Kong, 12 January 2013. In Hong Kong Medical Journal, 2013, v. 19 suppl. 1, p. 51, abstract no. 84 How to Cite?
AbstractINTRODUCTION: In formulating systemic treatment in patients with advanced stage lung cancer, it is now considered imperative to know the cell type such as squamous carcinoma, adenocarcinoma and large cell carcinoma as chemotherapeutic agents would be tailored to treat different cell types. In the authors’ centre, the adoption of using epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) as the firstline treatment has been the treatment of choice in patients shown to have activated EGFR mutation. Adequate tissue obtained during diagnostic procedures for cell typing and molecular profiling is therefore important in formulating personalised treatment in lung cancer patients nowa…
Persistent Identifierhttp://hdl.handle.net/10722/191672
ISSN
1024-2708
2021 Impact Factor: 1.256
2020 SCImago Journal Rankings: 0.357

 

DC FieldValueLanguage
dc.contributor.authorWong, MKYen_US
dc.contributor.authorLam, Den_US
dc.contributor.authorIp, Men_US
dc.contributor.authorHo, Jen_US
dc.date.accessioned2013-10-15T07:16:52Z-
dc.date.available2013-10-15T07:16:52Z-
dc.date.issued2013en_US
dc.identifier.citationThe 18th Medical Research Conference (MRC 2013), Department of Medicine, The University of Hong Kong, Hong Kong, 12 January 2013. In Hong Kong Medical Journal, 2013, v. 19 suppl. 1, p. 51, abstract no. 84en_US
dc.identifier.issn1024-2708-
dc.identifier.urihttp://hdl.handle.net/10722/191672-
dc.description.abstractINTRODUCTION: In formulating systemic treatment in patients with advanced stage lung cancer, it is now considered imperative to know the cell type such as squamous carcinoma, adenocarcinoma and large cell carcinoma as chemotherapeutic agents would be tailored to treat different cell types. In the authors’ centre, the adoption of using epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) as the firstline treatment has been the treatment of choice in patients shown to have activated EGFR mutation. Adequate tissue obtained during diagnostic procedures for cell typing and molecular profiling is therefore important in formulating personalised treatment in lung cancer patients nowa…-
dc.languageengen_US
dc.publisherHong Kong Academy of Medicine Press. The Journal's web site is located at http://www.hkmj.org.hk-
dc.relation.ispartofHong Kong Medical Journalen_US
dc.rightsHong Kong Medical Journal. Copyright © Hong Kong Academy of Medicine Press.-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectMedical sciences-
dc.titleEBUS-TBNA gives adequate tissue information on cell type in lung canceren_US
dc.typeConference_Paperen_US
dc.identifier.emailWong, MKY: drmwong@hku.hken_US
dc.identifier.emailLam, D: dcllam@hku.hken_US
dc.identifier.emailIp, M: msmip@hku.hken_US
dc.identifier.emailHo, J: jhocm@hku.hken_US
dc.identifier.authorityLam, D=rp01345en_US
dc.identifier.authorityIp, M=rp00347en_US
dc.identifier.authorityHo, J=rp00258en_US
dc.description.naturepublished_or_final_version-
dc.identifier.hkuros225332en_US
dc.identifier.volume19en_US
dc.identifier.issuesuppl. 1en_US
dc.identifier.spage51, abstract no. 84en_US
dc.identifier.epage51, abstract no. 84en_US
dc.publisher.placeHong Kong-
dc.customcontrol.immutablesml 131105-
dc.identifier.issnl1024-2708-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats